Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Centuria Capital (CNI.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-02-28	2.87	3.14	Neutral
2022-06-20	1.93	2.00	Neutral
2023-01-25	1.87	1.98	Neutral
2023-02-08	1.81	2.00	Neutral
2023-06-21	1.70	1.70	Neutral
2023-07-14	1.73	1.68	Neutral
2023-08-18	1.43	1.53	Neutral
2024-07-05	1.58	1.51	Sell
2024-09-24	2.09	1.74	Sell
2025-05-29	1.66	-	No Rating
2025-05-30	1.67	1.74	Sell

Disclosures

Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.